Summit X LLC’s Humana HUM Stock Holding History

Summit X LLC’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,949	Closed	-$728K	–	225
2024 Q3	$728K	Sell	1,949 -369	-16%	-$131K	0.18%	96
2024 Q2	$870K	Buy	2,318 +322	+16%	+$109K	0.2%	92
2024 Q1	$692K	Buy	+1,996	New	+$757K	0.18%	101

Other funds holding HUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Summit X LLC's HUM Position: Q4 2024 in Review

Summit X LLC sold out of Humana (HUM) in Q4 2024, closing a stake of 1,949 shares — an estimated $728K sold.

Summit X LLC first reported a position in HUM in Q1 2024 and held it in 3 quarters. The position peaked at $870K in Q2 2024. 878 funds tracked by Wall St. Rank hold HUM as of Q4 2024.

Summit X LLC reported no remaining Humana position as of Q4 2024 after selling out during the quarter.
Summit X LLC sold 1,949 Humana shares in Q4 2024, an estimated $728K.
Summit X LLC first reported a position in Humana in Q1 2024 and held it in 3 quarters.
Summit X LLC's Humana position peaked at $870K in Q2 2024.
878 funds tracked by Wall St. Rank held Humana as of Q4 2024.

Based on Summit X LLC's 13F filing for Q4 2024, filed 7 Feb 2025.